The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...

Friends for Hope is celebrating its 20th anniversary with the Heroes and Outlaws concert, featuring Grammy award-winning ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

A cross-continental study suggests that in the treatment of acute myeloid leukemia, age affects survival, independent of ...

Pfizer Inc. is rated a Buy with stable guidance, robust pipeline, strong free cash flows & appealing dividend yield. Learn ...

Q1 2026 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...

In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...

In this video, Leo I. Gordon, MD, FACP, discusses highlights from a debate at Lymphoma, Leukemia & Myeloma Congress on the evolving treatment landscape for relapsed or refractory diffuse large B-cell ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

Panelists examine the value of patient-reported outcomes (PROs) in helping guide therapy selection for later-line metastatic ...

After beating lung cancer, a Cleveland Clinic employee shares his story with patients facing their own health battles.

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...